United Therapeutics Financial Overview
United Therapeutics's market cap is currently $22.16B. The company's EPS TTM is $7.16; its P/E ratio is 19.51; United Therapeutics is scheduled to report earnings on October 29, 2025, and the estimated EPS forecast is $7.10. See an overview of income statement, balance sheet, and cash flow financials.
